Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Priya Miranda, Christopher D Cox, Michael Alexander, Slav Danev & Jonathan R T Lakey. (2020) In Quest of Pathognomonic/Endophenotypic Markers of Attention Deficit Hyperactivity Disorder (ADHD): Potential of EEG-Based Frequency Analysis and ERPs to Better Detect, Prevent and Manage ADHD. Medical Devices: Evidence and Research 13, pages 115-137.
Read now
Read now
S. L. Horrobin, N. A. McNair, I. J. Kirk & K. E. Waldie. (2008) Dexamphetamine Normalises Electrophysiological Activity in Attention Deficit-Hyperactivity Disorder during the Stroop Task. Neurocase 13:5-6, pages 301-310.
Read now
Read now
Joshua Slatkoff & Brian Greenfield. (2006) Pharmacological treatment of attention-deficit/hyperactivity disorder in adults. Expert Opinion on Investigational Drugs 15:6, pages 649-667.
Read now
Read now
Anouk Scheres, Jaap Oosterlaan & JosephA. Sergeant. (2006) Speed of Inhibition Predicts Teacher‐rated Medication Response in Boys with Attention Deficit Hyperactivity Disorder. International Journal of Disability, Development and Education 53:1, pages 93-109.
Read now
Read now
Stephen Rosenman. (2006) Reconsidering the attention deficit paradigm. Australasian Psychiatry 14:2, pages 127-132.
Read now
Read now
Articles from other publishers (76)
Cindy Boetzel, Heiko I. Stecher & Christoph S. Herrmann. (2023) ERP-aligned delta transcranial alternating current stimulation modulates the P3 amplitude. International Journal of Psychophysiology 193, pages 112247.
Crossref
Crossref
Christine A. Conelea, Sarah Morris, Nicole McLaughlin, Erin Mamaril, Kristen Benito, Brady Case & Abbe Garcia. (2022) Response inhibition in youth undergoing intensive treatment for obsessive compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders, pages 100764.
Crossref
Crossref
Adam T. Brockett & Matthew R. Roesch. (2021) Reactive and Proactive Adaptation of Cognitive and Motor Neural Signals during Performance of a Stop-Change Task. Brain Sciences 11:5, pages 617.
Crossref
Crossref
Ajay Kapur. (2020) Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?. CNS Drugs 34:10, pages 1045-1062.
Crossref
Crossref
Austin W. Blum & Jon E. Grant. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
373
385
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
295
425
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
A. Mühlberger, K. Jekel, T. Probst, M. Schecklmann, A. Conzelmann, M. Andreatta, A. A. Rizzo, P. Pauli & M. Romanos. (2016) The Influence of Methylphenidate on Hyperactivity and Attention Deficits in Children With ADHD: A Virtual Classroom Test. Journal of Attention Disorders 24:2, pages 277-289.
Crossref
Crossref
Ann-Marie Low, Signe Vangkilde, Julijana le Sommer, Birgitte Fagerlund, Birte Glenthøj, Jens Richardt Møllegaard Jepsen, Claus Bundesen, Anders Petersen & Thomas Habekost. (2018) Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment. Psychological Medicine 49:15, pages 2617-2625.
Crossref
Crossref
Maik Pertermann, Annet Bluschke, Veit Roessner & Christian Beste. (2019) The Modulation of Neural Noise Underlies the Effectiveness of Methylphenidate Treatment in Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 4:8, pages 743-750.
Crossref
Crossref
Jeyanthi S, Narkeesh Arumugam & Raju K. Parasher. (2018) Effect of physical exercises on attention, motor skill and physical fitness in children with attention deficit hyperactivity disorder: a systematic review. ADHD Attention Deficit and Hyperactivity Disorders 11:2, pages 125-137.
Crossref
Crossref
David R. Maguire & Charles P. France. (2019) Effects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time task. Psychopharmacology 236:6, pages 1959-1972.
Crossref
Crossref
Ann-Marie Low, Julijana le Sommer, Signe Vangkilde, Birgitte Fagerlund, Birte Glenthøj, Edmund Sonuga-Barke, Thomas Habekost & Jens Richardt Møllegaard Jepsen. (2018) Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment. International Journal of Neuropsychopharmacology 21:11, pages 997-1006.
Crossref
Crossref
Cheyenne Allenby, Mary Falcone, Leah Bernardo, E. Paul Wileyto, Anthony Rostain, J.Russell Ramsay, Caryn Lerman & James Loughead. (2018) Transcranial direct current brain stimulation decreases impulsivity in ADHD. Brain Stimulation 11:5, pages 974-981.
Crossref
Crossref
Natalie A Pride, Belinda Barton, Paul Hutchins, David R Coghill, Mayuresh S Korgaonkar, Stephen J C Hearps, Melissa Rouel, Stephanie Malarbi, Kathryn N North & Jonathan M Payne. (2018) Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial. BMJ Open 8:8, pages e021800.
Crossref
Crossref
Erich Studerus, Salvatore Corbisiero, Nadine Mazzariello, Sarah Ittig, Letizia Leanza, Laura Egloff, Katharina Beck, Ulrike Heitz, Christina Andreou, Rolf-Dieter Stieglitz & Anita Riecher-Rössler. (2020) Can neuropsychological testing facilitate differential diagnosis between at-risk mental state (ARMS) for psychosis and adult attention-deficit/hyperactivity disorder (ADHD)?. European Psychiatry 52, pages 38-44.
Crossref
Crossref
Michelle A. Pievsky & Robert E. McGrath. (2018) Neurocognitive effects of methylphenidate in adults with attention-deficit/hyperactivity disorder: A meta-analysis. Neuroscience & Biobehavioral Reviews 90, pages 447-455.
Crossref
Crossref
Patrick C. Dolder, Petra Strajhar, Patrick Vizeli, Alex Odermatt & Matthias E. Liechti. (2018) Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects. Psychopharmacology 235:5, pages 1389-1402.
Crossref
Crossref
Dong-dong Zhang, Yu-qiu Zhang & Xue-han Zhang. (2017) Prefrontal AMPA receptors are involved in the effect of methylphenidate on response inhibition in rats. Acta Pharmacologica Sinica 39:4, pages 607-615.
Crossref
Crossref
Stephen S. Tennyson, Adam T. Brockett, Nicholas W. Hricz, Daniel W. Bryden & Matthew R. Roesch. (2018) Firing of Putative Dopamine Neurons in Ventral Tegmental Area Is Modulated by Probability of Success during Performance of a Stop-Change Task. eneuro 5:2, pages ENEURO.0007-18.2018.
Crossref
Crossref
Annet Bluschke, Julia Friedrich, Marie Luise Schreiter, Veit Roessner & Christian Beste. (2018) A comparative study on the neurophysiological mechanisms underlying effects of methylphenidate and neurofeedback on inhibitory control in attention deficit hyperactivity disorder. NeuroImage: Clinical 20, pages 1191-1203.
Crossref
Crossref
Viviane Freire Bueno, Maria Aparecida da Silva, Tânia Maria Alves, Mario Rodrigues Louzã & Sabine Pompéia. (2014) Fractionating Executive Functions of Adults With ADHD. Journal of Attention Disorders 21:11, pages 944-955.
Crossref
Crossref
Gil Gonen-Yaacovi, Ayelet Arazi, Nitzan Shahar, Anat Karmon, Shlomi Haar, Nachshon Meiran & Ilan Dinstein. (2016) Increased ongoing neural variability in ADHD. Cortex 81, pages 50-63.
Crossref
Crossref
H. G. H. Tamminga, L. Reneman, H. M. Huizenga & H. M. Geurts. (2016) Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis. Psychological Medicine 46:9, pages 1791-1807.
Crossref
Crossref
X. Zhang, G.D. Newport, R. Callicott, S. Liu, J. Thompson, M.S. Berridge, S.M. Apana, W. SlikkerJr.Jr., C. Wang & M.G. Paule. (2016) MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates. Neurotoxicology and Teratology 56, pages 68-74.
Crossref
Crossref
Tamir Epstein, Nikolaos A Patsopoulos & Mark Weiser. (2016) Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Hsing-Chang Ni, Shoou-Lian Hwang Gu, Hsiang-Yuan Lin, Yu-Ju Lin, Li-Kuang Yang, Hui-Chun Huang & Susan Shur-Fen Gau. (2016) Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial. Journal of Psychopharmacology 30:5, pages 459-467.
Crossref
Crossref
Zheng Ye, Ellemarije Altena, Cristina Nombela, Charlotte R. Housden, Helen Maxwell, Timothy Rittman, Chelan Huddleston, Charlotte L. Rae, Ralf Regenthal, Barbara J. Sahakian, Roger A. Barker, Trevor W. Robbins & James B. Rowe. (2015) Improving Response Inhibition in Parkinson’s Disease with Atomoxetine. Biological Psychiatry 77:8, pages 740-748.
Crossref
Crossref
Viviane Freire Bueno, Elisa H. Kozasa, Maria Aparecida da Silva, Tânia Maria Alves, Mario Rodrigues Louzã & Sabine Pompéia. (2015) Mindfulness Meditation Improves Mood, Quality of Life, and Attention in Adults with Attention Deficit Hyperactivity Disorder. BioMed Research International 2015, pages 1-14.
Crossref
Crossref
Tamir Epstein, Nikolaos A Patsopoulos & Mark Weiser. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David A. Ziegler, Paymon Ashourian, Julien S. Wonderlick, Alison K. Sarokhan, Drazen Prelec, Clemens R. Scherzer & Suzanne Corkin. (2014) Motor impulsivity in Parkinson disease: Associations with COMT and DRD2 polymorphisms. Scandinavian Journal of Psychology 55:3, pages 278-286.
Crossref
Crossref
Gabriel J. Mazur, Gabriel Wood-Isenberg, Elizabeth Watterson & Federico Sanabria. (2014) Detrimental effects of acute nicotine on the response-withholding performance of spontaneously hypertensive and Wistar Kyoto rats. Psychopharmacology 231:12, pages 2471-2482.
Crossref
Crossref
Tannetje I. Bron, Denise Bijlenga, A. Marije Boonstra, Minda Breuk, Willem F.H. Pardoen, Aartjan T.F. Beekman & J.J. Sandra Kooij. (2014) OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: A randomized, placebo-controlled cross-over study. European Neuropsychopharmacology 24:4, pages 519-528.
Crossref
Crossref
Naomi A Fineberg, Samuel R. Chamberlain, Anna E. Goudriaan, Dan J. Stein, Louk J. M. J. Vanderschuren, Claire M. Gillan, Sameer Shekar, Philip A. P. M. Gorwood, Valerie Voon, Sharon Morein-Zamir, Damiaan Denys, Barbara J. Sahakian, F. Gerard Moeller, Trevor W. Robbins & Marc N. Potenza. (2014) New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectrums 19:1, pages 69-89.
Crossref
Crossref
A. Bari & T. W. Robbins. (2013) Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task. Psychopharmacology 230:1, pages 89-111.
Crossref
Crossref
Hsing-Chang Ni, Chi-Yung Shang, Susan Shur-Fen Gau, Yu-Ju Lin, Hui-Chun Huang & Li-Kuang Yang. (2013) A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder. International Journal of Neuropsychopharmacology 16:9, pages 1959-1973.
Crossref
Crossref
Bianca Jupp, Daniele Caprioli, Niel Saigal, Ingrid Reverte, Saurav Shrestha, Paul Cumming, Barry J. Everitt, Trevor W. Robbins & Jeffrey W. Dalley. (2013) Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex. European Journal of Neuroscience 37:9, pages 1519-1528.
Crossref
Crossref
Yueh-Ming Tai, Susan Shur-Fen Gau & Churn-Shiouh Gau. (2013) Injury-proneness of youth with attention-deficit hyperactivity disorder: A national clinical data analysis in Taiwan. Research in Developmental Disabilities 34:3, pages 1100-1108.
Crossref
Crossref
J.-M. Guilé. (2012) Psychostimulants. EMC - Psychiatrie 9:3, pages 1-9.
Crossref
Crossref
Leanne Tamm, Megan E. Narad, Tanya N. Antonini, Kathleen M. O’Brien, Larry W. HawkJr.Jr. & Jeffery N. Epstein. (2012) Reaction Time Variability in ADHD: A Review. Neurotherapeutics 9:3, pages 500-508.
Crossref
Crossref
Alexandra S. Potter, David J. Bucci & Paul A. Newhouse. (2011) Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology 220:2, pages 331-340.
Crossref
Crossref
J. K. Buitelaar, M. Casas, A. Philipsen, J. J. S. Kooij, J. A. Ramos-Quiroga, J. Dejonckheere, J. C. van Oene & B. Schäuble. (2011) Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate. Psychological Medicine 42:1, pages 195-204.
Crossref
Crossref
Jade C. Hill, Pablo Covarrubias, Joel Terry & Federico Sanabria. (2011) The effect of methylphenidate and rearing environment on behavioral inhibition in adult male rats. Psychopharmacology 219:2, pages 353-362.
Crossref
Crossref
J. Delisle & C. M. J. Braun. (2011) A Context for Normalizing Impulsiveness at Work for Adults with Attention Deficit/Hyperactivity Disorder (Combined Type). Archives of Clinical Neuropsychology 26:7, pages 602-613.
Crossref
Crossref
Jeffery R Wickens, Brian I Hyland & Gail Tripp. (2011) Animal models to guide clinical drug development in ADHD: lost in translation?. British Journal of Pharmacology 164:4, pages 1107-1128.
Crossref
Crossref
Sarah C. Jacobson, Mathieu Blanchard, Colm C. Connolly, Mary Cannon & Hugh Garavan. (2011) An fMRI investigation of a novel analogue to the Trail-Making Test. Brain and Cognition 77:1, pages 60-70.
Crossref
Crossref
Susanne Hellwig-BridaMonika DasekingFerdinand KellerFranz PetermannLutz Goldbeck. (2011) Effects of Methylphenidate on Intelligence and Attention Components in Boys with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 21:3, pages 245-253.
Crossref
Crossref
Jessica J.M. Barnes, Angela J. Dean, L. Sanjay Nandam, Redmond G. O'Connell & Mark A. Bellgrove. (2011) The Molecular Genetics of Executive Function: Role of Monoamine System Genes. Biological Psychiatry 69:12, pages e127-e143.
Crossref
Crossref
Jeffery N Epstein, William B Brinkman, Tanya Froehlich, Joshua M Langberg, Megan E Narad, Tanya N Antonini, Keri Shiels, John O Simon & Mekibib Altaye. (2011) Effects of Stimulant Medication, Incentives, and Event Rate on Reaction Time Variability in Children With ADHD. Neuropsychopharmacology 36:5, pages 1060-1072.
Crossref
Crossref
C. Keith Conners & Gill Sitarenios. 2011. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
681
683
.
A. Bari & T. W. Robbins. 2011. Molecular and Functional Models in Neuropsychiatry. Molecular and Functional Models in Neuropsychiatry
149
185
.
Chris Chandler. 2010. The Science of ADHD. The Science of ADHD
240
326
.
Monica Dhar, Pieter H. Been, Ruud B. Minderaa & Monika Althaus. (2010) Information processing differences and similarities in adults with dyslexia and adults with Attention Deficit Hyperactivity Disorder during a Continuous Performance Test: A study of cortical potentials. Neuropsychologia 48:10, pages 3045-3056.
Crossref
Crossref
Nirit Agay, Eldad Yechiam, Ziv Carmel & Yechiel Levkovitz. (2010) Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology 210:4, pages 511-519.
Crossref
Crossref
Alexandra Zagoloff & Scott J. Hunter. 2010. Principles and Practice of Lifespan Developmental Neuropsychology. Principles and Practice of Lifespan Developmental Neuropsychology
469
476
.
Dawn M. Eagle & Christelle Baunez. (2010) Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neuroscience & Biobehavioral Reviews 34:1, pages 50-72.
Crossref
Crossref
M Koesters, T Becker, R Kilian, JM Fegert & S Weinmann. (2008) Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. Journal of Psychopharmacology 23:7, pages 733-744.
Crossref
Crossref
Sarah V. Spencer, Larry W. HawkJr.Jr., Jerry B. Richards, Keri Shiels, William E. PelhamJr.Jr. & James G. Waxmonsky. (2009) Stimulant Treatment Reduces Lapses in Attention among Children with ADHD: The Effects of Methylphenidate on Intra-Individual Response Time Distributions. Journal of Abnormal Child Psychology 37:6, pages 805-816.
Crossref
Crossref
Andrea Bari, Dawn M. Eagle, Adam C. Mar, Emma S. J. Robinson & Trevor W. Robbins. (2009) Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 205:2, pages 273-283.
Crossref
Crossref
Katie Barrilleaux & Claire Advokat. (2008) Attribution and Self-Evaluation of Continuous Performance Test Task Performance in Medicated and Unmedicated Adults With ADHD. Journal of Attention Disorders 12:4, pages 291-298.
Crossref
Crossref
Steven Flanagan & Wayne A. Gordon. 2009. Neurovascular Neuropsychology. Neurovascular Neuropsychology
255
279
.
Iris Manor, Efrat Laiba, Jacques Eisenberg, Sheera Meidad, Elad Lerer, Salomon Israel, Inga Gritsenko, Sam Tyano, Stephen V. Faraone & Richard P. Ebstein. (2008) Association between trypotphan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B:8, pages 1501-1508.
Crossref
Crossref
Dawn M. Eagle, Andrea Bari & Trevor W. Robbins. (2008) The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology 199:3, pages 439-456.
Crossref
Crossref
Timothy E. Wilens. (2008) Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 28:3, pages S46-S53.
Crossref
Crossref
A. Marije Boonstra, J.J. Sandra Kooij, Jan K. Buitelaar, Jaap Oosterlaan, Joseph A. Sergeant, J.G.A.M. Angelien Heister & Barbara Franke. (2008) An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B:3, pages 397-402.
Crossref
Crossref
Emma S J Robinson, Dawn M Eagle, Adam C Mar, Andrea Bari, Gargi Banerjee, Xiaosu Jiang, Jeffrey W Dalley & Trevor W Robbins. (2007) Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat. Neuropsychopharmacology 33:5, pages 1028-1037.
Crossref
Crossref
F. Joseph McClernon, Scott H. Kollins, Avery M. Lutz, David P. Fitzgerald, Desiree W. Murray, Christina Redman & Jed E. Rose. (2007) Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology 197:1, pages 95-105.
Crossref
Crossref
Nanda N. J. Rommelse, Marieke E. Altink, Leo M. J. de Sonneville, Cathelijne J. M. Buschgens, Jan Buitelaar, Jaap Oosterlaan & Joseph A. Sergeant. (2007) Are Motor Inhibition and Cognitive Flexibility Dead Ends in ADHD?. Journal of Abnormal Child Psychology 35:6, pages 957-967.
Crossref
Crossref
Holly A. White. (2007) Inhibitory Control of Proactive Interference in Adults With ADHD. Journal of Attention Disorders 11:2, pages 141-149.
Crossref
Crossref
Steven R. PliszkaMario LiottiBrigitte Y. BaileyRicardo Perez IIIDavid GlahnMargaret Semrud-Clikeman. (2007) Electrophysiological Effects of Stimulant Treatment on Inhibitory Control in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 17:3, pages 356-366.
Crossref
Crossref
Samuel R. Chamberlain, Trevor W. Robbins & Barbara J. Sahakian. (2007) The Neurobiology of Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry 61:12, pages 1317-1319.
Crossref
Crossref
Dawn M. Eagle, Miles R. A. Tufft, Hannah L. Goodchild & Trevor W. Robbins. (2007) Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology 192:2, pages 193-206.
Crossref
Crossref
Yuki Kako, Yusuke Niwa, Atsuhito Toyomaki, Hiroyoshi Yamanaka, Nobuki Kitagawa, Kenzo Denda & Tsukasa Koyama. (2007) A case of adult attention-deficit/hyperactivity disorder alleviated by milnacipran. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:3, pages 772-775.
Crossref
Crossref
Samuel R Chamberlain, Ulrich Müller, Trevor W Robbins & Barbara J Sahakian. (2006) Neuropharmacological modulation of cognition. Current Opinion in Neurology 19:6, pages 607-612.
Crossref
Crossref
Alexandra S. Potter, Paul A. Newhouse & David J. Bucci. (2006) Central nicotinic cholinergic systems: A role in the cognitive dysfunction in Attention-Deficit/Hyperactivity Disorder?. Behavioural Brain Research 175:2, pages 201-211.
Crossref
Crossref
Anna E. Goudriaan, Jaap Oosterlaan, Edwin De Beurs & Wim Van Den Brink. (2006) Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 101:4, pages 534-547.
Crossref
Crossref